Literature DB >> 21140700

The use of extracorporeal membrane oxygenation in severe necrotizing soft tissue infections complicated by septic shock.

Michael S Firstenberg1, Erik Abel, Danielle Blais, Louis B Louis, Steven Steinberg, Chittoor Sai-Sudhakar, Stanley Martin, Benjamin Sun.   

Abstract

Necrotizing soft tissue infections remain a challenging clinical problem. Delays in diagnosis, incomplete débridement of necrotic tissues, and the hemodynamic instability and end-organ failure associated with overwhelming sepsis all contribute to significant mortality. Extracorporeal support is a well-established tool to support profound cardiopulmonary failure. To broaden the indications for use, we present two cases of young adults with necrotizing soft tissue infections who sustained sepsis-induced hemodynamic collapse and required extracorporeal support to facilitate adequate tissue débridement as a bridge to recovery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21140700

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  4 in total

Review 1.  Necrotizing Soft Tissue Infections: Surgeon's Prospective.

Authors:  Shashi Prakash Mishra; Shivanshu Singh; Sanjeev Kumar Gupta
Journal:  Int J Inflam       Date:  2013-12-24

2.  Duration of veno-arterial extracorporeal life support (VA ECMO) and outcome: an analysis of the Extracorporeal Life Support Organization (ELSO) registry.

Authors:  Myles Smith; Alexander Vukomanovic; Daniel Brodie; Ravi Thiagarajan; Peter Rycus; Hergen Buscher
Journal:  Crit Care       Date:  2017-03-06       Impact factor: 9.097

3.  Extracorporeal Life Support in Pregnancy: A Systematic Review.

Authors:  Emily E Naoum; Andrew Chalupka; Jonathan Haft; Mark MacEachern; Cosmas J M Vandeven; Sarah Rae Easter; Michael Maile; Brian T Bateman; Melissa E Bauer
Journal:  J Am Heart Assoc       Date:  2020-06-24       Impact factor: 5.501

Review 4.  A review of sepsis-induced cardiomyopathy.

Authors:  Ryota Sato; Michitaka Nasu
Journal:  J Intensive Care       Date:  2015-11-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.